← Back to catalogue

Maxpoint Br-I

FDA UDI

Class III (US FDA UDI)

by Novocure Inc

Identity

Trade Name
MAXPOINT BR-I FDA UDI
Generic Name
Alternating electric field antimitotic cancer treatment system generator FDA UDI
Device Name
Transducer Array Layout Planning software FDA UDI
Model / Reference
1.1.0 FDA UDI
Description
Transducer Array Layout Planning software FDA UDI

Identifiers

Catalog Number
SW000060 FDA UDI
Primary DI / UDI-DI
07290107983136 FDA UDI
FDA Product Code
NZK FDA UDI
GMDN Term
Alternating electric field antimitotic cancer treatment system generator FDA UDI

Classification

Device Class
Class III FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

No

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

Yes

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

No

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

No

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

No

FDA UDI

Manufacturing Date

No

FDA UDI

Category: Alternating electric field antimitotic cancer treatment system generator

Maxpoint Br-I by Novocure Inc — Class III — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Alternating electric field antimitotic cancer treatment system generator.

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Manufacturer
Novocure Inc

Sources (1)

  • FDA UDI 60ab74a4-2098-4c83-9702-5d2a805ec0d6 35 fields · synced May 30, 2026